REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Novo Nordisk Pharma EAD (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novo Nordisk Pharma EAD Profile Updated: December 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Global healthcare company Novo Nordisk established its Bulgarian subsidiary in 2005. The Sofia-based arm is mainly engaged in wholesaling pharmaceuticals.

Headquarters
Zlaten Rog 20-22, et. 8
Sofia; Sofia - city; Postal Code: 1407

Contact Details: Purchase the Novo Nordisk Pharma EAD report to view the information.

Website: http://www.novonordisk.bg/

Basic Information
Total Employees:
Purchase the Novo Nordisk Pharma EAD report to view the information.
Outstanding Shares:
Purchase the Novo Nordisk Pharma EAD report to view the information.
Registered Capital:
Purchase the Novo Nordisk Pharma EAD report to view the information.
Financial Auditors:
Purchase the Novo Nordisk Pharma EAD report to view the information.
Incorporation Date:
April 15, 2005
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novo Nordisk Pharma EAD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
13.84%▲
Total operating revenue
13.86%▲
Net Profit (Loss) for the Period
64.07%▲
Total assets
52.47%▲
Total equity
33.32%▲
Net Profit Margin
0.97%▲
Return on Equity (ROE)
4.15%▲
Quick Ratio
1.66%▲

Similar companies

Sopharma Trading AD
 
Sting AD
Pharmnet EAD
 
Alvogen Pharma Trading Europe EOOD
Huveproject EAD
 
Alta Pharmaceuticals EOOD
MagnaPharm Bulgaria EAD
 
Besta Med EOOD
L' Oreal Bulgaria EOOD
 
S&D Pharma Logistics BG EOOD
Merck Bulgaria EAD
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo